Hydrochloric Acid

Hydrochloric Acid

SCHEMBL2364155

CC1(C(=N)N)CCC1.Cl.Cl

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10433102 1.00
SCHEMBL317069 0.97
Hydrochloric Acid SCHEMBL18035951 0.94 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2
Hydrochloric Acid SCHEMBL9785542 0.92 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2
Water SCHEMBL30342292 0.92 ALDH1A1 (0.32) ALDH1A1SMN1; SMN2
SCHEMBL21238585 0.89 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2
SCHEMBL16137723 0.89 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2
Hydrochloric Acid SCHEMBL587935 0.88
SCHEMBL3664118 0.85
SCHEMBL22667559 0.74 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8574620-B2 Composite material for tissue repair SYNTHASOME, INC. (US) 2013-11-05 US claimed
US-20110206634-A1 COMPOSITE MATERIAL FOR TISSUE REPAIR SYNTHASOME, INC. (US) 2011-08-25 US claimed
EP-1321489-B1 Preparation and use of a nanocomposite of elastomer and exfoliated clay platelets formed in situ within an elastomer host and articles of manufacture, including tires, having at least one component comprised thereof GOODYEAR TIRE & RUBBER (US) 2008-04-30 EP claimed
EP-1474457-A1 METHOD OF MAKING ALTERNATING COPOLYMERS OF ISOBUTYLENE TYPE MONOMERS PPG Industries Ohio, Inc. (US) 2004-11-10 EP claimed
WO-2003070794-A1 METHOD OF MAKING ALTERNATING COPOLYMERS OF ISOBUTYLENE TYPE MONOMERS PPG INDUSTRIES OHIO, INC. (US) 2003-08-28 WO claimed
EP-1321489-A1 Preparation and use of a nanocomposite of elastomer and exfoliated clay platelets formed in situ within an elastomer host and articles of manufacture, including tires, having at least one component comprised thereof THE GOODYEAR TIRE & RUBBER COMPANY (US) 2003-06-25 EP claimed
EP-3423535-A1 AQUEOUS DISPERSIONS CONTAINING POLYMERIZATES PRODUCED IN MULTIPLE STAGES AND COATING AGENT COMPOSITIONS CONTAINING SAME BASF Coatings GmbH (DE) 2019-01-09 EP disclosed
US-8574620-B2 Composite material for tissue repair SYNTHASOME, INC. (US) 2013-11-05 US disclosed
US-20110206634-A1 COMPOSITE MATERIAL FOR TISSUE REPAIR SYNTHASOME, INC. (US) 2011-08-25 US disclosed
EP-1321489-B1 Preparation and use of a nanocomposite of elastomer and exfoliated clay platelets formed in situ within an elastomer host and articles of manufacture, including tires, having at least one component comprised thereof GOODYEAR TIRE & RUBBER (US) 2008-04-30 EP disclosed
US-7118900-B2 Directed assembly of functional heterostructures BIOARRAY SOLUTIONS LTD. (US) 2006-10-10 US disclosed
EP-1297039-A4 STRUCTURALLY-MODIFIED POLYMER FLOCCULANTS ONDEO NALCO CO (US) 2004-11-03 EP disclosed
EP-1381633-A1 SYNTHESIS OF VINYL POLYMERS BY CONTROLLED RADICAL POLYMERIZATION PPG Industries Ohio, Inc. (US) 2004-01-21 EP disclosed
US-20030138842-A1 Forming functionally organized, spatially patterned, alternating current mediated, self supporting, organic polymer-microparticle thin films/hydrogels SIRONA GENONICS, INC. 2003-07-24 US disclosed
EP-1321489-A1 Preparation and use of a nanocomposite of elastomer and exfoliated clay platelets formed in situ within an elastomer host and articles of manufacture, including tires, having at least one component comprised thereof THE GOODYEAR TIRE & RUBBER COMPANY (US) 2003-06-25 EP disclosed
EP-1297039-A1 STRUCTURALLY-MODIFIED POLYMER FLOCCULANTS Ondeo Nalco Company (US) 2003-04-02 EP disclosed
WO-2002085957-A1 SYNTHESIS OF VINYL POLYMERS BY CONTROLLED RADICAL POLYMERIZATION PPG INDUSTRIES OHIO, INC. (US) 2002-10-31 WO disclosed
WO-2002002662-A1 STRUCTURALLY-MODIFIED POLYMER FLOCCULANTS ONDEO NALCO COMPANY (US) 2002-01-10 WO disclosed